Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3845-3850

  Schwartz, Olivier ^a   Maréchal, Valérie ^a   Friguet, Bertrand ^a   Arenzana Seisdedos, Fernando ^a   Heard, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 2642670312     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3845-3850.1998     Document Type: Article

References (41)

1. Arthur, L. O., J. W. Bess, R. C. Sowder II, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
2. Arts, E. J., and M. A. Wainberg. 1996. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv. Virus Res. 46:97-163.
3. Best, S., P. Le Tissier, G. Towers, and J. P. Stoye. 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382:826-829.
4. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356.
5. Bukrinsky, M. I., N. Shavora, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90: 6125-6129.
6. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J.-K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non mammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
7. Charneau, P., G. Mirabeau, P. Roux, S. Paulous, H. Buc, and F. Clavel. 1994. HIV-1 reverse transcription: a termination step at the center of the genome. J. Mol. Biol. 241:651-662.
8. Ciechanover, A., and A. L. Schwartz. 1994. The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J. 8: 182-191.
9. Clapham, P. R. 1997. HIV and chemokines: ligands sharing cell-surface receptors. Trends Cell Biol. 7:264-268.
10. Coffin, J. 1996. Retrovirus restriction revealed. Nature 382:762-763.
11. Conconi, M., L. I. Szweda, R. L. Levine, E. R. Stadtman, and B. Friguet. 1996. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 331:232-240.
12. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
13. Drexler, H. C. 1997. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94:855-860.
14. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293-1300.
15. Farnet, C., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
16. Farnet, C. M., and F. D. Bushman. 1997. HIV-1 cDNA integration - requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:483-492.
17. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
18. Goff, S. P. 1996. Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 86:691-693.
19. Goldberg, A. L., and K. L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375-379.
20. Grimm, L. M., A. L. Goldberg, G. G. Poirier, L. M. Schwartz, and B. A. Osborne. 1996. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15:3835-3844.
21. Groettrup, M., A. Soza, U. Kuckelkorn, and P. M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429-435.
22. Groll, M., L. Ditzel, J. Lowe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386:463-471.
23. cdc2 activity. J. Virol. 69:6705-6711.
24. Hochstrasser, M. 1995. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:215-223.
25. Imajoh-Ohmi, S., T. Kawaguchi, S. Sugiyama, K. Tanaka, S. Omura, and H. Kikuchi. 1995. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217:1070-1077.
26. Karageorgos, L., P. Li, and C. Burrel. 1993. Characterization of HIV replication complexes early after cell-to-cell transmission. AIDS Res. Hum. Retroviruses 9:817-823.
27. Mansky, L. M. 1997. Accessory replication proteins and the accuracy of reverse transcription: implications for retroviral genetic diversity. Trends Genet. 13:134-136.
28. Maréchal, V., F. Clavel, J. M. Heard, and O. Schwartz. 1998. Cytosolic Gag p24 as an index of productive human immunodeficiency virus type 1 entry. J. Virol. 72:2208-2212.
29. Matlin, K. S., H. Reggio, A. Helenius, and K. Simons. 1982. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:609-631.
30. Michalek, M. T., E. P. Grant, C. Gramm, A. L. Goldberg, and K. L. Rock. 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class-I-restricted antigen presentation. Nature 363:552-554.
31. Miyanohara, A., J. K. Yee, K. Bouic, P. Laporte, and T. Friedmann. 1995. Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. Gene Ther. 2:138-142.
32. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J. L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J. M. Heard, I. Clark-Lewis, D. F. Legler, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine, stromal cell derived factor 1 (SDF-1), is the ligand for LESTR/fusin and prevents infection by lymphocyte-tropic HIV-1 syncytium-inducing strains. Nature 382:833-835.
33. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kB1 precursor protein and the activation of NF-kB. Cell 78:773-785.
34. Pitha, P. M. 1994. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antivir. Res. 24:205-219.
35. Poli, G., P. Biswas, and A. S. Fauci. 1994. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antivir. Res. 24: 221-233.
36. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC I molecules. Cell 78:761-771.
37. Roff, M., J. Thompson, M. S. Rodriguez, J. M. Jacque, F. Baleux, F. Arenzana-Seisdedos, and R. T. Hay. 1996. Role of IkB alpha ubiquitination in signal-induced activation of NF-kB in vivo. J. Biol. Chem. 271:7844-7850.
38. Schwartz, O., V. Maréchal, O. Danos, and J.-M. Heard. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:4053-4059.
39. Schwartz, O., J. L. Virelizier, L. Montagnier, and U. Hazan. 1990. A microtransfection method using luciferase gene for the study of human immunodeficiency virus long terminal repeat activity. Gene 88:197-205.
40. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-108. In J. A. Levy (ed.), The retroviridae, vol. 2. Plenum Press, New York, N.Y.
41. Whitcomb, J. M., and S. H. Hughes. 1992. Retroviral reverse transcription and integration: progress and problems. Annu. Rev. Cell Biol. 8:275-306.